Kallweit, Ulf MD; Jelcic, Ilijas MD; Braun, Nathalie MD, PhD; Fischer, Heike MD; Zörner, Björn MD; Schreiner, Bettina MD; Sokolov, Arseny A. MD; Martin, Roland MD; Weller, Michael MD; Linnebank, Michael MD
Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
Conflicts of Interest and Source of Funding: U.K. received honoraria from serving on an international expert panel meeting from Merck Serono. R.M. has received compensation for advisory functions or speakers assignments by Merck & Serono, Biogen, and Teva/Sanofi-Aventis. Furthermore, he has received project support by Merck & Serono and Biogen. M.W. received honoraria for advisory boards and research support from Merck Serono. M.L. received grants from Bayer Health Care, Biogen Idec, Merck Serono, Novartis, and Teva Pharmaceuticals. He has received personal compensation for participating in advisory boards and acting as consultant for Bayer Health Care, Biogen Idec, Merck-Serono, Novartis, and Teva Pharmaceuticals. For the remaining authors, none were declared.
There was no funding or sponsorship for this study.
Address correspondence and reprint requests to Michael Linnebank, MD, Department of Neurology, University Hospital Zurich, Zurich, Switzerland; E-mail: [email protected]
doi: 10.1097/WNF.0b013e31824644e6
